Dr. Daniel DeBrouse, molecular microbiologist and biotechnologist, is known for innovations in biomimicry, drug delivery, and biodegradable materials. Founder of MicroTech (1998), he pioneered rapid RNA-based pathogen assays. As a Syracuse University Research Professor (since 2008), he advanced oral insulin via SSNe nano-encapsulation (73–98% bioavailability), developed BioCrete eco-concrete, and led antiviral, fermentation, and biomimetic research as CEO/CSO of Tamarisk Technologies.